EZH2 and melanoma: Increased levels of EZH2 and H3K27me3, observed specifically in melanoma cell lines resistant to vemurafenib or its analog PLX4720, have triggered silencing of melanoma tumor suppressor phosphatase and tensin homolog (PTEN) (Vidarsdottir et al., 2021).